Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.
about
Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysisProspective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapyEffect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.Wide range of quasispecies diversity during primary hepatitis C virus infectionControl of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns.Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapyHepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral OutcomeHepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral TherapyHepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis CThe quasispecies nature and biological implications of the hepatitis C virusQuasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent mannerDeveloping novel oncolytic adenoviruses through bioselectionDeep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcomeAn overview of HCV molecular biology, replication and immune responses.Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation SequencingImpact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis CDiffering patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.Simplified hepatitis C virus genotyping by heteroduplex mobility analysis.Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.Genotyping hepatitis C virus by heteroduplex mobility analysis using temperature gradient capillary electrophoresis.Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions.
P2860
Q24800738-643B879A-D653-447E-8387-E85E972B3110Q27469310-8844C762-3EF3-40C4-AD09-266E5FE9E709Q27469364-63BAD94C-DD87-41DB-AFE4-9F7362BD3641Q27469430-5706B0EC-DAE2-4B62-98AC-D1C0AE8BE035Q27469500-D56E5074-6A97-4F46-8587-95FC58F7A166Q27469589-31F13D53-92DB-4ED8-B1C6-EBD7C9787250Q27469620-13808194-F54F-437E-AAC9-97E483FE23F2Q27469719-60428208-27A2-4F83-9A2C-30A533F3628AQ27469808-E44F4C14-4652-4E4A-A551-5A4ABEBA826EQ27472893-745A1E44-9054-45F7-BA23-223ACFB0F54BQ27472905-ADB602D9-C49D-462F-9D75-766977C55D12Q27478087-E09F0E50-7041-47BC-BA46-A8E32835F4F2Q27486013-EB0D5CFD-4138-4AFD-B352-EA5B02EDA027Q27486537-41C3AC37-DB9C-4FE0-B2AA-42F8944AE2D5Q27490497-8330AC39-BED2-4141-969E-B40B20E85DD2Q33834509-E6BD0D9C-8907-4FA0-9D5A-ABA5D8ACB5CBQ33836415-D33A6157-F84D-43F4-918C-D41C5531A5D0Q34471952-CFB571EF-094E-41C3-BDFA-D318E5E28494Q34485144-A84D8DFD-F872-4CBE-98F9-C825A2E4F457Q34916120-EB0CADD0-F6DA-41E7-8E43-22A9B0564C39Q35293895-110BAF78-F65A-4A8A-965D-8D6303D807A5Q35641185-ACFE1EE9-A4D0-4550-9A14-EC443A4F51EBQ35936933-63D75764-3052-4FF2-B39D-BDC096C2B594Q37322478-F16349DF-03DC-4FEB-8E83-C069C690C787Q37511130-1BD312FD-E3AA-4FC2-BC6E-3D3E4B84A3EFQ39455091-FEC4B10F-FFC4-45A7-A53D-69820B6746AAQ39603332-71457F5D-DB52-41BA-B002-82BD5BFCF708Q40181378-845917D4-AE6A-4D38-8168-622315DD17CCQ40763228-2A775E6C-EF88-4E83-8B55-9384E2F70D06
P2860
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Evolution of hepatitis C virus ...... therapy and natural infection
@nl
Evolution of hepatitis C virus ...... therapy and natural infection.
@ast
Evolution of hepatitis C virus ...... therapy and natural infection.
@en
type
label
Evolution of hepatitis C virus ...... therapy and natural infection
@nl
Evolution of hepatitis C virus ...... therapy and natural infection.
@ast
Evolution of hepatitis C virus ...... therapy and natural infection.
@en
prefLabel
Evolution of hepatitis C virus ...... therapy and natural infection
@nl
Evolution of hepatitis C virus ...... therapy and natural infection.
@ast
Evolution of hepatitis C virus ...... therapy and natural infection.
@en
P2093
P2860
P3181
P1433
P1476
Evolution of hepatitis C virus ...... therapy and natural infection
@en
P2093
B J McMahon
D G Sullivan
D R Gretch
J I Mullins
R L Carithers
S J Polyak
P2860
P304
P3181
P577
1998-05-01T00:00:00Z